Opendata, web and dolomites
Programme h2020-eu.3.1.7. [83 projects]
This page shows the list of projects involved in the programme "Innovative Medicines Initiative 2 (IMI2) (H2020-EU.3.1.7.)" of the Horizon 2020 Framework Research Programme.
Following table lists the European H2020 projects involved in the "H2020-EU.3.1.7." programme. Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | start | total cost | EC contribution | code call |
|---|---|---|---|---|---|
| 1 | EBODAC | 2014 | 20˙402˙786 | 20˙328˙856 | H2020-JTI-IMI2-2014-02-single-stage |
| 2 | EBOVAC2 | 2014 | 50˙710˙893 | 22˙790˙820 | H2020-JTI-IMI2-2014-02-single-stage |
| 3 | FILODIAG | 2015 | 2˙260˙105 | 2˙260˙105 | H2020-JTI-IMI2-2014-02-single-stage |
| 4 | Mofina | 2015 | 4˙398˙252 | 1˙162˙622 | H2020-JTI-IMI2-2014-02-single-stage |
| 5 | EbolaMoDRAD | 2015 | 4˙300˙935 | 4˙300˙935 | H2020-JTI-IMI2-2014-02-single-stage |
| 6 | INNODIA | 2015 | 35˙558˙967 | 17˙630˙000 | H2020-JTI-IMI2-2014-01-two-stage |
| 7 | VAC2VAC | 2016 | 16˙290˙929 | 7˙850˙000 | H2020-JTI-IMI2-2015-03-two-stage |
| 8 | PERISCOPE | 2016 | 29˙926˙682 | 21˙000˙000 | H2020-JTI-IMI2-2015-03-two-stage |
| 9 | RHAPSODY | 2016 | 18˙488˙749 | 8˙130˙000 | H2020-JTI-IMI2-2015-03-two-stage |
| 10 | PRISM | 2016 | 16˙195˙875 | 8˙080˙000 | H2020-JTI-IMI2-2015-03-two-stage |
| 11 | VSV-EBOPLUS | 2016 | 15˙430˙660 | 8˙553˙750 | H2020-JTI-IMI2-2015-08-single-stage |
| 12 | RADAR-CNS | 2016 | 25˙712˙110 | 11˙000˙000 | H2020-JTI-IMI2-2015-03-two-stage |
| 13 | BEAt-DKD | 2016 | 30˙163˙037 | 15˙085˙937 | H2020-JTI-IMI2-2015-05-two-stage |
| 14 | MOPEAD | 2016 | 4˙581˙967 | 2˙043˙000 | H2020-JTI-IMI2-2015-05-two-stage |
| 15 | ADAPTED | 2016 | 6˙796˙740 | 3˙510˙000 | H2020-JTI-IMI2-2015-05-two-stage |
| 16 | PREFER | 2016 | 12˙000˙001 | 6˙000˙000 | H2020-JTI-IMI2-2015-05-two-stage |
| 17 | AMYPAD | 2016 | 27˙329˙288 | 11˙999˙886 | H2020-JTI-IMI2-2015-05-two-stage |
| 18 | PHAGO | 2016 | 18˙088˙176 | 8˙838˙000 | H2020-JTI-IMI2-2015-05-two-stage |
| 19 | ROADMAP | 2016 | 8˙210˙381 | 3˙998˙250 | H2020-JTI-IMI2-2015-06-two-stage |
| 20 | RESCEU | 2017 | 25˙256˙452 | 14˙498˙125 | H2020-JTI-IMI2-2015-06-two-stage |
| 21 | IB4SD-TRISTAN | 2017 | 22˙641˙050 | 12˙000˙000 | H2020-JTI-IMI2-2015-07-two-stage |
| 22 | HARMONY | 2017 | 42˙205˙587 | 20˙200˙000 | H2020-JTI-IMI2-2015-06-two-stage |
| 23 | TransQST | 2017 | 17˙327˙874 | 8˙000˙000 | H2020-JTI-IMI2-2015-06-two-stage |
| 24 | ITCC-P4 | 2017 | 16˙562˙831 | 7˙370˙000 | H2020-JTI-IMI2-2015-07-two-stage |
| 25 | DO-IT | 2017 | 7˙191˙755 | 3˙549˙833 | H2020-JTI-IMI2-2015-07-two-stage |
| 26 | IMPRiND | 2017 | 11˙363˙398 | 4˙684˙998 | H2020-JTI-IMI2-2015-07-two-stage |
| 27 | BigData Heart | 2017 | 19˙398˙970 | 9˙664˙970 | H2020-JTI-IMI2-2015-07-two-stage |
| 28 | NGN-PET | 2017 | 3˙050˙000 | 1˙500˙000 | H2020-JTI-IMI2-2015-07-two-stage |
| 29 | PEVIA | 2017 | 17˙731˙397 | 6˙189˙570 | H2020-JTI-IMI2-2015-08-single-stage |
| 30 | DRIVE | 2017 | 9˙999˙937 | 8˙999˙812 | H2020-JTI-IMI2-2016-09-two-stage |
| 31 | MACUSTAR | 2017 | 16˙218˙917 | 8˙025˙000 | H2020-JTI-IMI2-2015-07-two-stage |
| 32 | eTRANSAFE | 2017 | 39˙490˙899 | 20˙000˙000 | H2020-JTI-IMI2-2016-09-two-stage |
| 33 | RTCure | 2017 | 13˙846˙865 | 6˙000˙000 | H2020-JTI-IMI2-2016-09-two-stage |
| 34 | EQIPD | 2017 | 9˙845˙483 | 4˙495˙523 | H2020-JTI-IMI2-2016-09-two-stage |
| 35 | LITMUS | 2017 | 47˙281˙406 | 15˙797˙881 | H2020-JTI-IMI2-2016-09-two-stage |
| 36 | COMBACTE-CDI | 2017 | 4˙179˙307 | 2˙312˙305 | H2020-JTI-IMI2-2016-09-two-stage |
| 37 | PARADIGM | 2018 | 9˙100˙277 | 4˙498˙931 | H2020-JTI-IMI2-2016-10-two-stage |
| 38 | IMI-PainCare | 2018 | 23˙200˙771 | 11˙225˙271 | H2020-JTI-IMI2-2016-10-two-stage |
| 39 | Hypo-RESOLVE | 2018 | 26˙774˙582 | 13˙450˙057 | H2020-JTI-IMI2-2016-10-two-stage |
| 40 | c4c | 2018 | 140˙496˙816 | 67˙000˙000 | H2020-JTI-IMI2-2016-10-two-stage |
| 41 | iConsensus | 2018 | 9˙400˙000 | 4˙700˙000 | H2020-JTI-IMI2-2016-10-two-stage |
| 42 | PIONEER | 2018 | 12˙763˙500 | 6˙000˙000 | H2020-JTI-IMI2-2016-10-two-stage |
| 43 | EBOVAC3 | 2018 | 29˙402˙655 | 29˙402˙655 | H2020-JTI-IMI2-2015-08-single-stage |
| 44 | GetReal Initiative | 2018 | 3˙100˙688 | 1˙750˙000 | H2020-JTI-IMI2-2017-11-single-stage |
| 45 | AIMS-2-TRIALS | 2018 | 113˙274˙914 | 54˙999˙998 | H2020-JTI-IMI2-2016-10-two-stage |
| 46 | ReSOLUTE | 2018 | 23˙850˙000 | 12˙000˙000 | H2020-JTI-IMI2-2016-10-two-stage |
| 47 | EFOEUPATI | 2018 | 604˙042 | 365˙242 | H2020-JTI-IMI2-2017-11-single-stage |
| 48 | WEB-RADR 2 | 2018 | 2˙121˙879 | 1˙168˙750 | H2020-JTI-IMI2-2017-11-single-stage |
| 49 | EHDEN | 2018 | 28˙917˙357 | 14˙105˙750 | H2020-JTI-IMI2-2017-12-two-stage |
| 50 | ESCulab | 2018 | 36˙729˙319 | 18˙249˙992 | H2020-JTI-IMI2-2017-12-two-stage |
| 51 | VITAL | 2019 | 12˙427˙217 | 5˙499˙882 | H2020-JTI-IMI2-2017-12-two-stage |
| 52 | FAIRplus | 2019 | 8˙228˙650 | 3˙996˙150 | H2020-JTI-IMI2-2017-12-two-stage |
| 53 | RADAR-AD | 2019 | 7˙640˙145 | 4˙999˙757 | H2020-JTI-IMI2-2017-12-two-stage |
| 54 | NECESSITY | 2019 | 15˙425˙020 | 8˙200˙000 | H2020-JTI-IMI2-2017-12-two-stage |
| 55 | IM2PACT | 2019 | 17˙410˙136 | 9˙000˙000 | H2020-JTI-IMI2-2017-12-two-stage |
| 56 | PD-MitoQUANT | 2019 | 6˙882˙315 | 4˙497˙935 | H2020-JTI-IMI2-2017-13-two-stage |
| 57 | TransBioLine | 2019 | 27˙906˙491 | 13˙999˙997 | H2020-JTI-IMI2-2017-13-two-stage |
| 58 | NEURONET | 2019 | 2˙353˙125 | 1˙199˙125 | H2020-JTI-IMI2-2017-13-two-stage |
| 59 | NeuroDeRisk | 2019 | 9˙752˙062 | 5˙331˙000 | H2020-JTI-IMI2-2017-13-two-stage |
| 60 | EBiSC2 | 2019 | 8˙872˙547 | 4˙599˙648 | H2020-JTI-IMI2-2017-13-two-stage |
| 61 | CARDIATEAM | 2019 | 12˙882˙500 | 6˙700˙000 | H2020-JTI-IMI2-2017-13-two-stage |
| 62 | IMMUcan | 2019 | 34˙937˙500 | 17˙830˙000 | H2020-JTI-IMI2-2017-13-two-stage |
| 63 | VALUE-Dx | 2019 | 13˙739˙927 | 6˙799˙100 | H2020-JTI-IMI2-2017-13-two-stage |
| 64 | BIOMAP | 2019 | 20˙884˙846 | 10˙499˙999 | H2020-JTI-IMI2-2017-13-two-stage |
| 65 | MOBILISE-D | 2019 | 49˙361˙564 | 25˙395˙897 | H2020-JTI-IMI2-2017-13-two-stage |
| 66 | ConcePTION | 2019 | 28˙778˙406 | 15˙299˙991 | H2020-JTI-IMI2-2017-13-two-stage |
| 67 | RespiriNTM | 2019 | 8˙060˙640 | 5˙687˙983 | H2020-JTI-IMI2-2018-16-single-stage |
| 68 | STOPFOP | 2019 | 1˙999˙712 | 999˙710 | H2020-JTI-IMI2-2017-13-two-stage |
| 69 | PD-MIND | 2019 | 2˙131˙609 | 999˙698 | H2020-JTI-IMI2-2017-13-two-stage |
| 70 | TRIC-TB | 2019 | 8˙373˙250 | 6˙926˙375 | H2020-JTI-IMI2-2018-16-single-stage |
| 71 | RespiriTB | 2019 | 9˙962˙900 | 6˙840˙000 | H2020-JTI-IMI2-2018-16-single-stage |
| 72 | MELLODDY | 2019 | 18˙410˙465 | 8˙000˙000 | H2020-JTI-IMI2-2018-14-two-stage |
| 73 | AB-DiRecT | 2019 | 3˙789˙717 | 3˙429˙217 | H2020-JTI-IMI2-2018-16-single-stage |
| 74 | GNA NOW | 2019 | 31˙415˙987 | 12˙299˙995 | H2020-JTI-IMI2-2018-16-single-stage |
| 75 | Trials@Home | 2019 | 38˙331˙269 | 19˙036˙997 | H2020-JTI-IMI2-2018-14-two-stage |
| 76 | 3TR | 2019 | 80˙803˙177 | 40˙273˙191 | H2020-JTI-IMI2-2018-14-two-stage |
| 77 | Immune-Image | 2019 | 27˙200˙801 | 15˙000˙000 | H2020-JTI-IMI2-2018-14-two-stage |
| 78 | EU-PEARL | 2019 | 26˙238˙047 | 12˙004˙952 | H2020-JTI-IMI2-2018-15-two-stage |
| 79 | COMBINE | 2019 | 25˙460˙100 | 8˙000˙000 | H2020-JTI-IMI2-2018-15-two-stage |
| 80 | IDEA-FAST | 2019 | 40˙922˙058 | 20˙997˙522 | H2020-JTI-IMI2-2018-15-two-stage |
| 81 | ERA4TB | 2020 | 207˙963˙991 | 89˙815˙600 | H2020-JTI-IMI2-2018-15-two-stage |
| 82 | PharmaLedger | 2020 | 20˙920˙901 | 8˙290˙693 | H2020-JTI-IMI2-2018-15-two-stage |
| 83 | ImmUniverse | 2020 | 31˙110˙000 | 15˙500˙000 | H2020-JTI-IMI2-2018-15-two-stage |
| - | - | - | 1˙990˙752˙536.00 | 994˙717˙238.00 | - |